Search research articles
Contact Us
Filters
Showing results (401-410 of 436) with videos related to
Page
of 44
Sort By:
American Journal of Hematology
|
October 20, 2017
Hyper-CVAD plus nelarabine in newly diagnosed adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma
Yasmin Abaza, Hagop M Kantarjian, Stefan Faderl, et al.
Haematologica
|
February 16, 2015
Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia
Marina Konopleva, Peter F Thall, Cecilia Arana Yi, et al.
Blood
|
May 5, 2022
Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms
Adam S Sperling, Veronica A Guerra, James A Kennedy, et al.
Cancer Discovery
|
November 10, 2018
Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study
Naval Daver, Guillermo Garcia-Manero, Sreyashi Basu, et al.
Cancer
|
August 7, 2025
Contemporary outcomes of octa-nonagenarians with newly diagnosed acute myeloid leukemia
Jayastu Senapati, Hagop M Kantarjian, Tapan M Kadia, et al.
JCO Precision Oncology
|
December 10, 2025
Clinical Outcomes of Adult Patients With Newly Diagnosed Mixed Phenotype Acute Leukemia
Hannah Goulart, Farhad Ravandi, Nicholas J Short, et al.
American Journal of Hematology
|
September 2, 2022
Contemporary outcomes in IDH-mutated acute myeloid leukemia: The impact of co-occurring NPM1 mutations and venetoclax-based treatment
Curtis A Lachowiez, Patrick K Reville, Hagop Kantarjian, et al.
Blood Cancer Discovery
|
March 8, 2021
Patterns of Resistance Differ in Patients with Acute Myeloid Leukemia Treated with Type I versus Type II FLT3 inhibitors
Ahmad S Alotaibi, Musa Yilmaz, Rashmi Kanagal-Shamanna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 28, 2018
Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia
Kiyomi Morita, Hagop M Kantarjian, Feng Wang, et al.
Blood
|
September 7, 2018
A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis
Lucia Masarova, Srdan Verstovsek, Juliana E Hidalgo-Lopez, et al.
Page
of 44
Search research articles
Search
Showing results (401-410 of 436) with videos related to
Sort By:
Page
of 44
American Journal of Hematology
|
October 20, 2017
Hyper-CVAD plus nelarabine in newly diagnosed adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma
Yasmin Abaza, Hagop M Kantarjian, Stefan Faderl, et al.
Haematologica
|
February 16, 2015
Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia
Marina Konopleva, Peter F Thall, Cecilia Arana Yi, et al.
Blood
|
May 5, 2022
Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms
Adam S Sperling, Veronica A Guerra, James A Kennedy, et al.
Cancer Discovery
|
November 10, 2018
Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study
Naval Daver, Guillermo Garcia-Manero, Sreyashi Basu, et al.
Cancer
|
August 7, 2025
Contemporary outcomes of octa-nonagenarians with newly diagnosed acute myeloid leukemia
Jayastu Senapati, Hagop M Kantarjian, Tapan M Kadia, et al.
JCO Precision Oncology
|
December 10, 2025
Clinical Outcomes of Adult Patients With Newly Diagnosed Mixed Phenotype Acute Leukemia
Hannah Goulart, Farhad Ravandi, Nicholas J Short, et al.
American Journal of Hematology
|
September 2, 2022
Contemporary outcomes in IDH-mutated acute myeloid leukemia: The impact of co-occurring NPM1 mutations and venetoclax-based treatment
Curtis A Lachowiez, Patrick K Reville, Hagop Kantarjian, et al.
Blood Cancer Discovery
|
March 8, 2021
Patterns of Resistance Differ in Patients with Acute Myeloid Leukemia Treated with Type I versus Type II FLT3 inhibitors
Ahmad S Alotaibi, Musa Yilmaz, Rashmi Kanagal-Shamanna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 28, 2018
Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia
Kiyomi Morita, Hagop M Kantarjian, Feng Wang, et al.
Blood
|
September 7, 2018
A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis
Lucia Masarova, Srdan Verstovsek, Juliana E Hidalgo-Lopez, et al.
Page
of 44